GE Healthcare, a unit of General Electric Company, announces the addition of the WAVE Bioreactor™, part of the ReadyToProcess portfolio, to the list of GE ecomagination approved offerings aimed at ...

Chalfont St. Giles, UK (Apr. 16)-GE Healthcare, a unit of General Electric ... This concept was developed into the company’s “Wave Bioreactor,” which it introduced in 1998. Further technical ...

GE Healthcare Life Sciences, makers of the Wave platform of single-use bioreactors, has approached the debate over whether stainless steel or single-use technology is more advantageous at various ...

Disposables play an obvious role in scaleup, i.e., that form factors for smaller single-use cell culture vessels (e.g. GE Healthcare’s Wave Bioreactor™ systems) can be identical to production ...

Using GE Healthcare's single-use WAVE Bioreactor and ReadyToProcess crossflow filtration system, the team developed a novel process for the production, clarification, and concentration of CMV-like ...

DUBLIN--(BUSINESS WIRE)--The "Global Bioreactors Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The bioreactors market will register a CAGR of almost 7% by 2023.

will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as antibodies and vaccines. Financial terms were not disclosed. Wave Biotech ...